Breast Pathology and Cancer Diagnosis

Roberto N Miranda has completed his MD at the Universidad Peruana Cayetano Heredia, in Lima, Peru and after emigrating to United States, completed an AP CP Residency at Brown University, fellowship in Hematopathology at Vanderbilt University, and has been Faculty at MD Anderson Cancer Center since 2007, where he is currently working as a Professor in the Department of Hematopathology. He has an interest in T-cell lymphomas and has developed an expertise in breast implant-associated anaplastic large cell lymphoma, a topic on which he has several landmark publications and book chapters, and on which he has lectured nationally and internationally.

Oncology

Hallgeir Rui is a PhD holder and serves as the WBCS Endowed Professor of Breast Cancer Research in the Department of Pathology at the Medical College of Wisconsin, Milwaukee, WI. He has previously held positions at Thomas Jefferson University, Philadelphia, PA, Georgetown University, Washington DC, and Uniformed Services University, Bethesda, MD. He completed his Post-doctoral training at NCI, Frederick, MD and Moffitt Cancer Center, Tampa, FL. He received his MD and PhD degrees at the University of Oslo, Norway. His laboratory research is centered on analyses of human breast cancer to improve tailored therapy.

Oncology

Feng Yan is the Vice Director of Department of Clinical Laboratory in Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Cancer Hospital. The research works focus on the Bioanalytical Chemistry in laboratory medical diagnostics, particularly in detection of tumor markers and tumor cells. She has published 42 papers in SCI journals.

Oncology